OPRX - OptimizeRx Corp

QQQ $ 442.84 $ 1.02 (0.23 %)

DIA $ 394.52 $ -0.72 (-0.18 %)

SPY $ 520.61 $ 0.07 (0.01 %)

TLT $ 90.36 $ 0.23 (0.26 %)

GLD $ 216.28 $ -2.45 (-1.12 %)

Previous Close

$ 10.54

Open

$ 10.91

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 10.35 - $ 10.91

52 Week Range

$ 6.92 - $ 16.65

Volume

91,739

Average Volume

Market Cap

180.5M

Beta (5Y Monthly)

$ 1.34

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	04-15-2024	12-31-2023	10-K
2	11-14-2023	09-30-2023	10-Q
3	08-14-2023	06-30-2023	10-Q
4	05-12-2023	03-31-2023	10-Q
5	03-10-2023	12-31-2022	10-K
6	11-08-2022	09-30-2022	10-Q
7	08-09-2022	06-30-2022	10-Q
8	05-09-2022	03-31-2022	10-Q
9	02-28-2022	12-31-2021	10-K
10	11-09-2021	09-30-2021	10-Q
11	08-04-2021	06-30-2021	10-Q
12	05-06-2021	03-31-2021	10-Q
13	03-08-2021	12-31-2020	10-K
14	11-09-2020	09-30-2020	10-Q
15	08-05-2020	06-30-2020	10-Q
16	05-06-2020	03-31-2020	10-Q
17	03-26-2020	12-31-2019	10-K
18	11-05-2019	09-30-2019	10-Q
19	08-07-2019	06-30-2019	10-Q
20	05-08-2019	03-31-2019	10-Q
21	03-12-2019	12-31-2018	10-K
22	11-05-2018	09-30-2018	10-Q
23	08-07-2018	06-30-2018	10-Q
24	05-02-2018	03-31-2018	10-Q
25	03-08-2018	12-31-2017	10-K
26	11-02-2017	09-30-2017	10-Q
27	08-01-2017	06-30-2017	10-Q
28	05-03-2017	03-31-2017	10-Q
29	03-08-2017	12-31-2016	10-K
30	11-07-2016	09-30-2016	10-Q
31	08-08-2016	06-30-2016	10-Q
32	05-09-2016	03-31-2016	10-Q
33	03-15-2016	12-31-2015	10-K
34	11-12-2015	09-30-2015	10-Q
35	08-11-2015	06-30-2015	10-Q
36	05-14-2015	03-31-2015	10-Q
37	03-31-2015	12-31-2014	10-K
38	11-13-2014	09-30-2014	10-Q
39	08-14-2014	06-30-2014	10-Q
40	05-15-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

OptimizeRx Corporation Says 1Q24 Revenue E...
04/26/2024 11:37:50

For the first quarter, the Company expects revenue to increase over 40% year-over-year and come in between $18.5 million and $1...

JMP Securities Reiterates Market Outperfor...
04/16/2024 15:18:48

JMP Securities analyst Constantine Davides reiterates OptimizeRx (NASDAQ:OPRX) with a Market Outperform and maintains $15 pr...

OptimizeRx Sees FY24 Revenue Of $100M Vs. ...
04/16/2024 11:08:14

OptimizeRx Q4 Adj EPS $0.26, Inline, Sales...
04/16/2024 11:06:03

OptimizeRx (NASDAQ:OPRX) reported quarterly adjusted earnings of $0.26 per share which met the analyst consensus estimate. This...

JMP Securities Initiates Coverage On Optim...
04/04/2024 09:02:53

JMP Securities analyst Constantine Davides initiates coverage on OptimizeRx (NASDAQ:OPRX) with a Market Outperform rating an...

Where OptimizeRx Stands With Analysts
04/01/2024 18:00:37

Stifel Maintains Buy on OptimizeRx, Mainta...
04/01/2024 15:05:16

Stifel analyst David Grossman maintains OptimizeRx (NASDAQ:OPRX) with a Buy and maintains $13 price target.

RBC Capital Reiterates Outperform on Optim...
04/01/2024 13:50:42

RBC Capital analyst Sean Dodge reiterates OptimizeRx (NASDAQ:OPRX) with a Outperform and maintains $17 price target.

Earnings Scheduled For March 28, 2024
03/28/2024 09:24:44

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

OptimizeRx Earnings Preview
03/27/2024 17:01:50

OptimizeRx Reaffirms Prior Revenue In The ...
03/11/2024 20:35:11

OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), the leading provider of healthcare technology solutions helping life s...

RBC Capital Maintains Outperform on Optimi...
01/10/2024 15:03:56

RBC Capital analyst Sean Dodge maintains OptimizeRx (NASDAQ:OPRX) with a Outperform and raises the price target from $14 to ...

OptimizeRx Says Prelim, 2023 Revenue Is Ex...
01/09/2024 12:33:49

Barclays Initiates Coverage On OptimizeRx ...
01/03/2024 10:41:48

Barclays analyst Stephanie Davis initiates coverage on OptimizeRx (NASDAQ:OPRX) with a Equal-Weight rating and announces Pri...

Earnings Scheduled For November 6, 2023
11/06/2023 13:24:53

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on ...

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
11/06/2023 13:06:45

OptimizeRx Expects FY23 Revenues To Be Bet...
11/06/2023 12:19:19

2023 Financial Outlook Based on OptimizeRx's results for the first nine months of 2023 and its recent acquisition, the Com...

OptimizeRx Q3 Adj EPS $0.09 Up From $0.07 ...
11/06/2023 12:01:56

OptimizeRx (NASDAQ:OPRX) reported quarterly adjusted earnings of $0.09 per share. This is a 28.57 percent increase over earning...

A Preview Of OptimizeRx's Earnings
11/03/2023 20:00:58

digital-health-tech-optimizerxs-acquisition-of-medicx-health-to-boost-earnings-and-market-potential-analyst

Digital Health Tech OptimizeRx's Acquisiti...
10/12/2023 17:42:46

OptimizeRx Corp (NASDAQ: OPRX) agreed to acquire Scottsdale, Arizona-based Healthy Offers Inc, dba Medicx Health,